Top 10 Managed Healthcare Companies To Own In Right Now

If you bought a U.S. equity fund this year, there's about a 98% chance you invested in a fund managed by the Vanguard Group Inc.

Vanguard, best known for its index funds and emphasis on low-cost investing, received $41.4 billion of net inflows into its U.S equity funds in 2013 through Nov. 30, according to Morningstar Inc. U.S. stock funds not managed by the company founded by John C. Bogle in 1974 took in a net total of about $1.1 billion.

Much of Vanguard's success in attracting investors is thanks to Mr. Bogle's creation — the index fund. Of the $41.4 billion invested in its domestic equity funds this year, about $36 billion went into the firm's U.S. equity index mutual funds, including the $296.4 billion Vanguard Total Stock Market Fund (VITSX), which passed the $244 billion Pimco Total Return Fund (PTTAX) as the world's largest mutual fund last month.

Top 10 Managed Healthcare Companies To Own In Right Now: Horizon Technology Finance Corporation (HRZN)

Horizon Technology Finance Corporation, a specialty finance company, lends to and invests in development-stage companies in the United States. It provides secured loans to companies backed by established venture capital and private equity firms in the technology, life science, healthcare information and services, and cleantech industries. Horizon Technology Finance Corporation was founded in 2008 and is based in Farmington, Connecticut.

Advisors' Opinion:

• [By BDC Buzz]

  I believe investors should look past the current low dividend yields and relatively higher multiples of NAV per share for BDCs such as FDUS, MAIN, and TCAP, but should consider the total return for these companies. The table below compares FDUS and MAIN to both ACAS which does not pay dividends and Horizon Technology Finance (HRZN) that pays a higher than average dividend but after taking into account dividend growth, special dividends, and NAV per share growth (using last twelve months actual for projection purposes) it is clear that the expected investor return is based on more than the current dividend yield.

Top 10 Managed Healthcare Companies To Own In Right Now: Astronics Corporation(ATRO)

Astronics Corporation, through its subsidiaries, designs and manufactures products for the aerospace and defense industries worldwide. It operates in two segments, Aerospace and Test Systems. The Aerospace segment?s product lines include aircraft lighting, cabin electronics, airframe power, avionics databus products, and airfield lighting. This segment serves airframe manufacturers that build aircraft for the commercial, military, and general aviation markets; suppliers; and aircraft operators, such as airlines and branches of the U.S. Department of Defense, as well as the Federal Aviation Administration and airport operators. The Test Systems segment designs, develops, manufactures, and maintains communications and weapons test systems, and training and simulation devices for military applications. It sells its products primarily to the U.S. military, foreign militaries, and manufacturers of military communication systems. The company was founded in 1968 and is headquart ered in East Aurora, New York.

Advisors' Opinion:

• [By Jeremy Bowman]

  What: Shares of Astronics Corporation (NASDAQ: ATRO  ) were headed for the stars today, gaining 11% after a strong quarterly earnings report.

• [By Rich Smith]

  Astronics Corp. (NASDAQ: ATRO  ) is bulking up in aerospace.

  On Tuesday, the manufacturer of high-performance lighting, electrical power, and automated test systems for the global aerospace and defense industries announced that it has agreed to buy fellow aerospace interior components maker PECO for approximately $136 million, cash. Privately owned PECO is a supplier to Boeing and a maker of fuel access doors and also "passenger service units" that incorporate air handling, emergency oxygen, electrical power management, and cabin lighting systems.�

• [By Victor Selva]

  Having to deal with competitors such as Astronics Cp (ATRO) or B/E Aerospace Inc. (BEAV), and being able to maintain a competitive position in the market, shows ATS麓s ability for great evolution and profitable growth.

10 Best Specialty Retail Stocks To Watch Right Now: Givaudan SA (GIVN)

Givaudan SA is a Switzerland-based holding company engaged in the fragrance and flavor industry. The Company has two business divisions: Fragrances and Flavors. The Fragrances business segment comprises the manufacture and sale of fragrances into three global business units: Fine Fragrances, comprising signature fragrances and line extensions, Consumer Products, comprising fabric and personal care, hair and skin care, household and air care, as well as oral care, and Fragrance Ingredients. The Flavors business division comprises the manufacture and sale of flavors into four business units: Beverages, comprising flavors for soft drinks, fruit juices and instant beverages; Dairy, comprising ice cream, yoghurt, desserts and yellow fats; Savory, covering soups and sauces, among others; and Confectionery. The Company is also engaged in research and development activities, which comprises the development of a palette of perfumery raw materials, both synthetic and natural. Advisors' Opinion:

• [By Celeste Perri]

  Nestle SA (NESN) is selling Givaudan (GIVN) SA shares worth $1.27 billion at yesterday�� closing price to institutional investors, winding down its stake in the world�� largest flavorings maker.

• [By Inyoung Hwang]

  Berkeley Group Holdings Plc (BKG) surged 8.3 percent after saying first-half profit rose 22 percent. London Stock Exchange Group Plc (LSE) climbed 2.4 percent after Bank of America Corp.�� Merrill Lynch unit recommended buying the stock. Givaudan SA (GIVN) lost 1.3 percent after Nestle SA said it will sell $1.27 billion of shares in the world�� largest flavorings maker.

Top 10 Managed Healthcare Companies To Own In Right Now: Ambit Biosciences Corp (AMBI)

Ambit Biosciences Corporation, incorporated on May 17, 2000, is a biopharmaceutical company. The Company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. The Company�� lead drug candidate, quizartinib, is in Phase IIb clinical development in patients with relapsed/refractory acute myeloid leukemia (AML). The Company�� second drug candidate in clinical development, AC410, is a potent, selective, orally-administered, small molecule inhibitor of Janus kinase 2 (JAK2) that has potential utility for the treatment of autoimmune and inflammatory diseases. The Company�� third program consists of two selective small molecule compounds, AC708 and AC855, which inhibit the colony-stimulating factor-1 receptor (CSF1R), a receptor tyrosine kinase.

Quizartinib

The Company�� lead drug candidate, quizartinib, is a once-daily, orally-administered, potent and selective inhibitor of FLT3, a validated target in the treatment of AML, and is in Phase IIb clinical development. The FLT3-ITD mutation acts like a power switch that causes leukemic cells, or blasts, to spread more aggressively and grow back more rapidly following chemotherapy, conferring an especially poor survival outcome. Quizartinib is designed to turn off this switch. The Company is developing a companion diagnostic test with Genoptix Medical Laboratory, a Novartis company, to identify FLT3-ITD positive patients.

AC410

The Company�� advanced drug candidate, AC410, is a potent, selective, orally-administered, small molecule inhibitor of JAK2, which has potential utility for the treatment of autoimmune and inflammatory diseases. Signaling through JAK controls the activation, proliferation and survival of various types of immune cells, and overactivation of such cells can exacerbate a range of normal inflammatory processes, resulting i! n inflammation. The Company�� initial JAK2 drug candidate, AC430, is a racemic mixture (50/50) of two enantiomers (mirror images), AC410 and AC409, and was studied in a Phase I clinical trial.

CSF1R Program

The Company is developing two potent and exquisitely selective small molecule compounds, AC708 and AC855 that both inhibit CSF1R and have potential utility in oncology, autoimmune and inflammatory diseases. Signaling through CSF1R controls the activation, proliferation and survival of macrophages, which are key mediators of immune system function and over-activation of macrophages, may result in exacerbation of certain diseases.

The Company competes with Abbvie Inc., Akinion Pharmaceuticals AB, Amgen Inc., ARIAD Pharmaceuticals, Inc., AROG Pharmaceuticals, LLC, ArQule, Inc., Astellas, AstraZeneca plc, Bayer AG, Celgene Corporation, Daiichi-Sankyo Company Limited, Galapagos NV, GlaxoSmithKline plc, Incyte Corporation, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Eli Lilly and Company, Novartis, Onyx Pharmaceuticals, Inc., Pfizer, Rigel Pharmaceuticals, Inc., F. Hoffman-LaRoche Ltd, and Vertex Pharmaceuticals Incorporated.

Advisors' Opinion:

• [By Wallace Witkowski]

  Ambit Biosciences Corp. (AMBI) �shares fell more than 37% to $8 in moderate volume. The small-cap biotech said it will not file an accelerated approval application with the Food and Drug Administration for its leukemia drug quizartinib after the agency disagreed with the company about the use of certain study data to support the drug�� efficacy.

Top 10 Managed Healthcare Companies To Own In Right Now: Tanger Factory Outlet Centers Inc.(SKT)

Tanger Factory Outlet Centers, Inc. operates as a real estate investment trust (REIT). The company, through its subsidiary, Tanger Properties Limited Partnership, engages in acquiring, developing, owning, operating, and managing factory outlet shopping centers. As of September 30, 2005, Tanger owned and operated 33 factory outlet centers in 22 states totaling 8.7 million square feet of gross leasable area. It also provides development, leasing, and management services for its outlet centers. The company has elected to be taxed as a REIT under the Internal Revenue Code. As a REIT, it would not be subject to Federal income taxes provided it distributes at least 90% of its taxable income to its shareholders. Tanger Factory Outlet Centers was founded by Stanley K. Tanger in 1981. The company is headquartered in Greensboro, North Carolina.

Advisors' Opinion:

• [By James E. Brumley]

  What do small cap stocks MKS Instruments, Inc. (NASDAQ:MKSI), Tanger Factory Outlet Centers Inc. (NYSE:SKT), and Kaman Corporation (NYSE:KAMN) have in common? Absolutely nothing, on the surface, and no, it's not a setup for painfully bad punchline. There is a common thread among KAMN, SKT, and MKSI right now, however... they're all three going into my mental (though publicly-tracked) portfolio this afternoon.

• [By Shauna O'Brien]

  Jefferies announced on Wednesday that it has cut its rating on Tanger Factory Outlet Centers Inc. (SKT).

  The firm has downgraded SKT from “Buy” to “Hold,” and has lowered the company’s price target from $40 to $35. This price target suggests an 8% upside from the stock’s current price of $32.22.

  Analyst Omotayo Okusanya commented: “We expect near-term headwinds for the mall and outlet mall segment as tenant sales growth appears to be slowing.”

  “At SKT, development yields on two projects have also been reduced. Further, rising interest rates negatively impact our DDM-derived PT. Our lowered PT of $35 represents a 10% total return over the next-twelve-months (NTM); we are downgrading to Hold,” added the analyst.

  Tanger Factory Outlet shares were mostly flat during pre-market trading Wednesday. The stock is up more than 5% YTD.

• [By Rich Duprey]

  Shopping center REIT�Tanger Factory Outlet Centers� (NYSE: SKT  ) announced yesterday its second-quarter dividend of $0.225 per share, the same rate it paid last quarter after raising the payout 7%, from $0.21 per share.

• [By U.S. News]

  Linda Davidson/The Washington Post via Getty ImagesShoppers at the Tanger Outlet Mall in Oxon Hill, Md. There are few forms of shopping I enjoy more than outlet shopping. There is something about all of those discount stores packed so closely together that makes me super excited! But I am not going to tell you that all outlet stores are a good deal, because some of them are not. Also, brands sometimes create cheaper items to sell specifically in their outlet locations, and those are not always a smart buy. But for the most part, outlet malls are still an excellent way to save some money while picking up items for the entire family. Here are five ways to make the most of your trip to an outlet: 1. Figure out the outlet 'brand.' There are a couple of management companies that own quite a few outlet malls in the United States, including Premium Outlets (SPG) and Tanger Factory Outlet Centers (SKT). Before heading out, be sure to check the website for the entire outlet mall for any possible deals or coupons. Premium and Tanger Outlets also have Facebook (FB) pages where they will occasionally post coupons that you can print from home. 2. Look for an outlet discount card or VIP program. Many outlet malls have VIP savings programs that can save you big bucks throughout the year and also give you special access to new promotions and sales. The Fashion Outlets of Chicago opened last year and offer a Green Savings Card that costs $5 for a yearly membership. Those with a Green Savings Card receive extra discounts at a huge number of stores and restaurants in the mall, which is on top of the already low prices. 3. 'Like' the outlet store on Facebook. If there is an outlet store that you frequent, go ahead and like its Facebook page so that you will be one of the first to know about sales and promotions. The Kate Spade Outlet (KATE) will frequently post promotions to Facebook before emailing subscribers. The J. Crew Factory Store has offered special promotions th

Top 10 Managed Healthcare Companies To Own In Right Now: Legg Mason Inc. (LMI)

LMI Aerospace Inc. provides structural assemblies, kits and components, and design engineering services to the aerospace and defense markets in the United States. The company�s Aerostructures segment fabricates, machines, finishes, integrates, assembles, and kits machined and formed close tolerance aluminum, specialty alloy, composite components, and assemblies. Its products include wing slats and flap skins/components, and ailerons; winglet edges and modification kits; fuselage and wing skins; wing panels; helicopter cabin and aft section components; tail cone and edge assemblies; thrust reversers and engine nacelles/cowlings; door components, assemblies, and floor beams; cockpit window frames and landing light lens; and cockpit crew floor and bulkhead structure assemblies. This segment also provides wheel well and electronic rack assemblies; interior components; structural sheet metal, machined, milled, and extruded components; housings and assemblies; auxiliary power u nit components; fans and heat exchangers; ProWall engineered containers; and assemblies and components for rail yard switching equipment. Its Engineering Services segment offers engineering design, analysis, repair, certification, and program management services. This segment provides structural design and analysis services, including wing/wingbox, fixed and moveable leading edges/trailing edges, empennage, and tail cone design; winglet/wing mod design; nacelle, engine cowl, and thrust reverser design; weight improvement engineering; helicopter fuselage, cockpit, cabin frames, skins, longerons, and beams; and aircraft modification engineering services. It also offers systems design and integration, tool design and fabrication, manufacturing engineering, after-market engineering and support, aviation training system, and aviation maintenance engineering; and aviation system software engineering services. LMI Aerospace Inc. was founded in 1948 and is based in St. Charles, Miss ouri.

Advisors' Opinion:

• [By Sofia Horta e Costa]

  Lonmin Plc (LMI) jumped 2.8 percent to 295 pence, extending its biggest weekly rally in almost four months. Morgan Stanley upgraded the shares to overweight from equal weight, meaning that investors should buy more of the shares. The brokerage described their valuation as attractive.

Top 10 Managed Healthcare Companies To Own In Right Now: Westpac Banking Corp (WEBNF)

Westpac Banking Corporation is a banking company. It operates through three divisions: Australian Financial Services (AFS), Westpac Institutional Bank (WIB) and Westpac New Zealand. AFS consists of Westpac�� retail and business banking operations in Australia, and includes Westpac Retail & Business Banking (Westpac RBB), St.George Banking Group and BT Financial Group Australia (BFTG). Westpac RBB is responsible for sales and service for consumer, small-to-medium enterprise customers and commercial customers under the Westpac brands. St.George is responsible for sales, and service for its consumer, business and corporate customers in Australia under brands, such as St.George and BankSA. BTFG is Westpac�� Australian wealth management division. In January 2014, the Company completed the acquisition of Lloyds Banking Group Plc�� Australian asset finance business, Capital Finance Australia Limited, and its Australian corporate loan portfolio, BOS International (Australia) Ltd. Advisors' Opinion:

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- Australian stocks edged lower Thursday, as a mostly soft lead from the U.S. markets helped weigh on the S&P/ASX 200 (AU:XJO) , which lost 0.2% to 5,306.40. Mining stocks moved mostly lower as a rising dollar depressed some key commodity prices overnight, with Oz Minerals Ltd. (AU:OZL) (OZMLF) down 1%, Fortescue Metals Group Ltd. (AU:FMG) (FSUMF) off 1.5%, and Newcrest Mining Ltd. (AU:NCM) (NCMGF) 1.1% lower. The big four banks all started lower as well, with Australia & New Zealand Banking Group (AU:ANZ) (ANEWF) and Commonwealth Bank of Australia (AU:CBA) (CBAUF) down 0.2% each, while National Australia Bank Ltd. (AU:NAB) (NAUBF) lost 0.4%, and Westpac Banking Corp. (AU:WBC) (WEBNF) fell 0.5%. Retailers were mixed ahead of retail-sales data due out later in the day, as Harvey Norman Holdings Ltd. (AU:HVN) (HNORY) fell 0.5% and Myer Holdings Ltd. (AU:MYR) lost 0.7%, while David Jones Ltd.

Top 10 Managed Healthcare Companies To Own In Right Now: Huron Consulting Group Inc.(HURN)

Huron Consulting Group Inc. provides operational and financial consulting services in the United States. Its Health and Education Consulting segment develops and implements solutions to help clients address financial management, strategy, operational and organizational effectiveness, research administration, and regulatory compliance; and offers consulting services related to organization performance improvement, revenue cycle improvement, turnarounds, merger or affiliation strategies, labor productivity, non-labor cost management, information technology, patient flow improvement, physician practice management, interim management, clinical quality and medical management, and governance and board development to hospitals, health systems, physicians, managed care organizations, academic medical centers, colleges, universities, and pharmaceutical and medical device manufacturers. The company?s Legal Consulting segment provides strategic and management consulting, cost managem ent, and technology and information management, including matter management, records, document review, and discovery services to assist law departments and law firms. This segment also offers V3locity solution, which delivers streamlined e-discovery process; and IMPACT solution that delivers sustainable cost reductions. Its Financial Consulting segment assists corporations with accounting and financial reporting matters, and provides financial analysis in restructuring and turnaround situations, as well as consults with companies in the areas of corporate governance, Sarbanes Oxley compliance, and internal audit. Huron Consulting Group Inc. serves various industries, including healthcare, education, professional services, pharmaceutical, technology, transportation services, telecommunications, financial services, electronics, consumer products, governmental, energy and utilities, and industrial manufacturing. The company was founded in 2002 and is headquartered in Chicago, I llinois.

Advisors' Opinion:

• [By Benjamin Shepherd] The US health care industry is among the heaviest regulated in the nation. Most health care-related companies must answer to federal, state and, in many cases, local regulators.
  
  That regulatory burden will only grow more complex, as myriad new rules under the Patient Protection and Affordable Care Act, or “Obamacare,” come into effect over the next few months. In just 22 days, the first insurance exchanges are supposed to come online. On January 1, the individual mandate and changes in coverage standards become effective.
  
  Many health care businesses and organizations were dragging their feet in complying with Obamacare’s provisions, waiting to see how the Supreme Court would come down on the law. The court didn’t rule on Obamacare until June 2012, a decision in which it upheld the law almost in its entirety.
  
  Given that delayed decision, a study conducted by the Government Accountability Office this past June found that only 44 percent of key activities required for full compliance had been completed, particularly where health insurance exchanges were concerned.
  
  As a result, there’s a massive scramble underway to achieve minimum compliance levels with the law. But there’s a paucity of workers with the requisite knowledge of federal and insurance regulations required to help companies and state governments navigate the labyrinth of regulations.
  
  That’s creating a lot of work for consultancies such as Huron Consulting Group (NSDQ: HURN), which focuses almost exclusively on the health care sector.
  
  While the company also works in the legal, financial, education and life sciences arenas, it primarily helps hospitals, health systems and physician groups reduce costs, maximize reimbursements from both federal and private insurers and transition towards the value-based care mandated under Obamacare. In future years, reimbursements will transition towards rewarding health care organizations tha

Top 10 Managed Healthcare Companies To Own In Right Now: ARIAD Pharmaceuticals Inc.(ARIA)

ARIAD Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company?s lead cancer product, ridaforolimus is being studied in multiple clinical trials in patients with various types of cancers, including metastatic sarcomas, breast cancer, endometrial cancer, prostate cancer, and non-small cell lung cancer. Its product pipeline also includes ponatinib, a pan BCR-ABL inhibitor in phase 2 clinical trial for applications in various hematological cancers and solid tumors; and AP26113, an anaplastic lymphoma kinase inhibitor in preclinical studies for the treatment of various cancers, including non-small cell lung cancer, lymphoma, and neuroblastoma. In addition, the company focuses on a drug discovery program centered on small-molecule therapies that are molecularly targeted to cell-signaling pathways implicated in cancer. Further, it licenses its ARGENT cell-sign aling regulation technologies to pharmaceutical and biotechnology companies to develop and commercialize therapeutic products, and to conduct drug discovery research. The company has collaboration and license agreements with Merck & Co., Inc. for the development, manufacture, and commercialization of ridaforolimus; and license agreements with Medinol Ltd. and ICON Medical Corp. to develop and commercialize stents and other medical devices to deliver ridaforolimus to prevent restenosis of injured vessels. ARIAD Pharmaceuticals, Inc. was founded in 1991 and is based in Cambridge, Massachusetts.

Advisors' Opinion:

• [By Roberto Pedone]

  One under-$10 biopharmaceutical player that's just starting to enter breakout territory is Ariad Pharmaceuticals (ARIA), which is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules. This stock has been crushed by the sellers so far in 2013, with shares down huge by 82%.

  If you take a look at the chart for Ariad Pharmaceuticals, you'll notice that this stock has gapped down big over the last month, with the first gap sending the stock from around $19 to $4 a share with massive downside volume. The second gap sent ARIA from $4.50 to its recent low of $2.62 a share with big downside volume. Since hitting that $2.62 low, shares of ARIA have now started to rebound off oversold territory, since its current relative strength index reading is 17.92. That move is starting to push shares of ARIA into breakout territory, since the stock is flirting with some near-term overhead resistance at $3.27 today.

  Traders should now look for long-biased trades in ARIA if it manages to take out some near-term overhead resistance at $3.27 and once it clears Thursday's intraday high of $3.38 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 8.03 million shares. If we get that move soon, then ARIA will set up to re-fill some of that second gap down zone that started at $4.53 a share. Shares of ARIA could easily tag its next major overhead resistance level at $5.98 a share if that gap gets filled with strong upside volume flows.

  Traders can look to buy ARIA off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $3.01 a share. One can also buy ARIA off strength once it clears those resistance levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 10 Managed Healthcare Companies To Own In Right Now: Liberty Media Corporation(LINTA)

Liberty Interactive, Inc. markets and sells a range of consumer products in the United States and internationally, primarily by means of televised shopping programs on the QVC networks and via the Internet through its Websites. It also provides online content, products, and services to consumers, publishers, and advertisers; performance gear products for backpacking, climbing, skiing, snowboarding, trail running, and adventure travel; supplements, clothing, tanning supplies, accessories, and other bodybuilding products, as well as hosts an online site where visitors could network and exchange information related to bodybuilding; nutraceutical and cosmeceutical products; integration and fulfillment solutions for multi-channel ecommerce merchants; online invitation and social event planning service; tools and information needed to research, plan, book, and experience travel for business and leisure travelers; and gift ideas and interactive, personalized shopping services. In addition, the company offers retailer and interactive lifestyle network products through television home shopping programming on HSN television network and HSN.com; membership services to the vacation ownership industry; commerce, content, and community converge services; perishable products; residential and commercial video, high-speed data, and voice services over its broadband cable systems; and filmed entertainment, interactive services, television networks, cable systems, and music and publishing. Further, it operates as a catalog and online retailer of party supplies and costumes; ecommerce and traditional retailer of premium baby gear and products that provide parents an assortment of products for their babies, such as travel gear, feeding, d�or, and toys; and an online lending and real estate business, which matches consumers with lenders and loan brokers. The company is headquartered in Englewood, Colorado.

Advisors' Opinion:

• [By Anders Bylund]

  Robert "Dob" Bennett was CEO of Liberty Interactive (NASDAQ: LINTA  ) from 1997 to 2005. He steered the Internet-leaning company through the dot-com bust and came out stronger. Under Bennett's leadership, Liberty Interactive grew annual sales from $1.2 billion to $7.6 billion. He's been known to stand up to Liberty chairman John Malone on occasion, and he still serves as a board member or executive in several of Liberty's offshoots.

• [By Victor Selva]

  The company has a current ratio of 13.45% which is higher than the one registered by Liberty Interactive Corp (LINTA). But for investors looking for a higher ROE, Time Warner Cable, DISH Network Corp (DISH), Rogers Communications, Inc. (RCI), Shaw Communications, Inc. (SJR) and Tivo, Inc. (TIVO) could be better options.